Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection

BACKGROUND: The majority of those infected by ancestral Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) during the UK first wave (starting March 2020) did not require hospitalisation. Most had a short-lived mild or asymptomatic infection, while others had symptoms that persisted for wee...

Descripción completa

Detalles Bibliográficos
Autores principales: Captur, Gabriella, Moon, James C., Topriceanu, Constantin-Cristian, Joy, George, Swadling, Leo, Hallqvist, Jenny, Doykov, Ivan, Patel, Nina, Spiewak, Justyna, Baldwin, Tomas, Hamblin, Matt, Menacho, Katia, Fontana, Marianna, Treibel, Thomas A., Manisty, Charlotte, O'Brien, Ben, Gibbons, Joseph M., Pade, Corrina, Brooks, Tim, Altmann, Daniel M., Boyton, Rosemary J., McKnight, Áine, Maini, Mala K., Noursadeghi, Mahdad, Mills, Kevin, Heywood, Wendy E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515404/
https://www.ncbi.nlm.nih.gov/pubmed/36182629
http://dx.doi.org/10.1016/j.ebiom.2022.104293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515404/
https://www.ncbi.nlm.nih.gov/pubmed/36182629
http://dx.doi.org/10.1016/j.ebiom.2022.104293

Ejemplares similares